314 related articles for article (PubMed ID: 12882406)
21. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
22. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.
Radfar A; Unnikrishnan I; Lee HW; DePinho RA; Rosenberg N
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13194-9. PubMed ID: 9789064
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe SW; Sherr CJ
Curr Opin Genet Dev; 2003 Feb; 13(1):77-83. PubMed ID: 12573439
[TBL] [Abstract][Full Text] [Related]
24. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
[TBL] [Abstract][Full Text] [Related]
25. p16 and ARF: activation of teenage proteins in old age.
Satyanarayana A; Rudolph KL
J Clin Invest; 2004 Nov; 114(9):1237-40. PubMed ID: 15520854
[TBL] [Abstract][Full Text] [Related]
26. p16(Ink4a) in melanocyte senescence and differentiation.
Sviderskaya EV; Hill SP; Evans-Whipp TJ; Chin L; Orlow SJ; Easty DJ; Cheong SC; Beach D; DePinho RA; Bennett DC
J Natl Cancer Inst; 2002 Mar; 94(6):446-54. PubMed ID: 11904317
[TBL] [Abstract][Full Text] [Related]
27. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16
Wang JL; Wu JH; Hong C; Wang YN; Zhou Y; Long ZW; Zhou Y; Qin HS
Pathol Res Pract; 2017 Dec; 213(12):1542-1551. PubMed ID: 29042141
[TBL] [Abstract][Full Text] [Related]
29. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
Soufir N; Basset-Seguin N
Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
[TBL] [Abstract][Full Text] [Related]
30. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
Haferkamp S; Scurr LL; Becker TM; Frausto M; Kefford RF; Rizos H
J Invest Dermatol; 2009 Aug; 129(8):1983-91. PubMed ID: 19212341
[TBL] [Abstract][Full Text] [Related]
31. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
32. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N
Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538
[TBL] [Abstract][Full Text] [Related]
33. The INK4A/ARF locus and its two gene products.
Sharpless NE; DePinho RA
Curr Opin Genet Dev; 1999 Feb; 9(1):22-30. PubMed ID: 10072356
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus.
Gibson SL; Dai CY; Lee HW; DePinho RA; Gee MS; Lee WM; Furth EE; Brensinger C; Enders GH
Cancer Res; 2003 Feb; 63(4):742-6. PubMed ID: 12591718
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis.
Orlow I; Rabbani F; Chin L; Pomerantz J; Ligeois N; Dudas M; Depinho R; Cordón-Cardó C
Int J Oncol; 1999 Jul; 15(1):17-24. PubMed ID: 10375589
[TBL] [Abstract][Full Text] [Related]
36. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
38. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
[TBL] [Abstract][Full Text] [Related]
39. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
[TBL] [Abstract][Full Text] [Related]
40. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
Huot TJ; Rowe J; Harland M; Drayton S; Brookes S; Gooptu C; Purkis P; Fried M; Bataille V; Hara E; Newton-Bishop J; Peters G
Mol Cell Biol; 2002 Dec; 22(23):8135-43. PubMed ID: 12417717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
